Overview of your opportunity
The Technology Innovation Agency (TIA), South Africa, and BioCubaFarma (BCF), Cuba, have extended their joint Expression of Interest (EOI): South Africa–Cuba Biotechnology Collaboration to Friday, 27 February 2026. This EOI seeks South African partners to collaborate with Cuban institutions on technology transfer, joint development, and joint ventures for innovative biotech products, with a strong focus on therapies for neurodegenerative and chronic diseases such as Parkinson’s disease, Multiple Sclerosis, Dementia, lung cancer, and Alzheimer’s Disease.